Cyprus Securities and Exchange Commission

MariMed Reports Third Quarter 2023 Earnings

Retrieved on: 
Wednesday, November 8, 2023
Adjustment, Sale, IRS, Boston, SEDAR, EBITDA, GAAP, Cyprus Securities and Exchange Commission, Capital expenditure, THC, Forecasting, Castle of Castro Marim, Capital, Bank, Cryptocurrency, Tutoring, Asset management

MariMed management will host a conference call on Thursday, November 9, 2023 at 8:00 a.m. Eastern time, to discuss these results.

Key Points: 
  • MariMed management will host a conference call on Thursday, November 9, 2023 at 8:00 a.m. Eastern time, to discuss these results.
  • The conference call may be accessed through MariMed’s Investor Relations website, or by clicking the following link: MRMD Q323 Earnings Call .
  • During the third quarter, the Company announced the following developments in the implementation of its strategic growth plan:
    July 1: MariMed commenced adult-use retail and wholesale operations in Maryland.
  • July 13: MariMed staged the ‘Boston 280E THC Party’ in Boston Harbor to protest unfair cannabis industry tax laws.

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

Retrieved on: 
Wednesday, November 8, 2023
Pharmaceutical, Health, Medical Supplies, Medical Devices, Linda, KRMD, Worldwide, Security (finance), NYSE, International, Compensated emancipation, Life, Master of Business Administration, University of Chicago, Laboratory, EBITDA, Roche, Novo Nordisk, Cyprus Securities and Exchange Commission, Organization, Reckitt, NASCO, University of Chicago Booth School of Business, Quality of life, Growth, BDX, Business administration, Marketing, Employment, Business, State university system, University, BD (company), Chief commercial officer, Patient, State University of New York, Pharmaceutical industry, Management

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Ken Miller as Chief Commercial Officer, effective November 6, 2023.

Key Points: 
  • KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Ken Miller as Chief Commercial Officer, effective November 6, 2023.
  • As Chief Commercial Officer, Ken will have oversight of the global commercial function including U.S. and International sales and marketing organizations.
  • He joins KORU Medical with impressive medical device and pharmaceutical industry experience, most recently from NASCO Healthcare where he spent five years as President & CEO.
  • Ken also held leadership roles in marketing, sales, and business development with Novo Nordisk, Adams Respiratory Therapeutics, and Roche Laboratories.

Spire Global Announces Strong Third Quarter 2023 Results; Reaffirms Expectations for Positive Cash Flow from Operations by Year End; Increases Revenue and Earnings Guidance

Retrieved on: 
Wednesday, November 8, 2023
Technology, Other Defense, Contracts, Satellite, Other Technology, Aerospace, Manufacturing, Government Technology, Hardware, Defense, Adjustment, Loss, ExactEarth, ARR, Security (finance), Tax, Mission Control Space Services, Life, Public expenditure, EBITDA, Cyprus Securities and Exchange Commission, FASB, GAAP, Acquisition, Judgement, Bank statement, Nature, Growth, Weather, COVID-19, Risk, Marketing, Webcast, File, Depreciation, Forecasting, Sumathi Best Television Current Reporting Award, Table, Failure, Accounting, Cryptocurrency, Bank, Insurance, Bookkeeping, Spire, Aviation

Please see the reconciliation tables at the end of this release for the reconciliation of GAAP and non-GAAP results.

Key Points: 
  • Please see the reconciliation tables at the end of this release for the reconciliation of GAAP and non-GAAP results.
  • Spire adjusts the following items from one or more of its non-GAAP financial measures:
    Loss on satellite deorbit, launch failure and decommissioning.
  • Spire excludes these items as they do not reflect the underlying cash flows or operational results of the business.
  • Spire defines free cash flow as net cash used in operating activities reduced by purchases of property and equipment.

Hut 8 Provides Update on Business Combination with USBTC

Retrieved on: 
Wednesday, November 8, 2023
Bitcoin, Hut 8, Transaction, Data mining, Cyprus Securities and Exchange Commission, TSX, ESG, Cryptocurrency

TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Hut 8 Mining Corp. (Nasdaq: HUT ) (TSX: HUT ), ("Hut 8” or the “Company”) one of North America’s largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, continues to make progress on the proposed business combination pursuant to which Hut 8 and U.S. Data Mining Group, Inc. dba US Bitcoin Corp (“USBTC”) will combine in an all-stock merger of equals (the “Transaction”).

Key Points: 
  • TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Hut 8 Mining Corp. (Nasdaq: HUT ) (TSX: HUT ), ("Hut 8” or the “Company”) one of North America’s largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, continues to make progress on the proposed business combination pursuant to which Hut 8 and U.S. Data Mining Group, Inc. dba US Bitcoin Corp (“USBTC”) will combine in an all-stock merger of equals (the “Transaction”).
  • The combined company will be named “Hut 8 Corp.” (“New Hut”) and will be a U.S.-domiciled entity.
  • New Hut has filed a further amendment to its Form S-4 Registration Statement (the “Amended S-4 Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”).
  • Completion of the Transaction remains subject to the remaining regulatory approvals, approval of the stockholders of USBTC and other customary closing conditions of the transaction.

Greif, Inc. Attends Baird Global Industrial Conference; Reaffirms Fiscal Year 2023 Guidance

Retrieved on: 
Wednesday, November 8, 2023
Adjustment, Insurance, Risk, Instability, 600 (number), NYSE, Health, GIP, Pressure, News, Conference, Cyprus Securities and Exchange Commission, Greif, Inc., Information technology, COVID-19, PPS, Form 10-K, OCC, Privacy, XXV, Rationalization, Conference call, XV, Video game

DELAWARE, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today reaffirms that fiscal 2023 results will be within the previously provided guidance range of Adjusted EBITDA of $790 million to $820 million1 in anticipation of participation in the Baird Global Industrial Conference in Chicago, IL on Wednesday, November 8, 2023.

Key Points: 
  • DELAWARE, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today reaffirms that fiscal 2023 results will be within the previously provided guidance range of Adjusted EBITDA of $790 million to $820 million1 in anticipation of participation in the Baird Global Industrial Conference in Chicago, IL on Wednesday, November 8, 2023.
  • This guidance reaffirmation is attributable to performance in-line with expectations for the fiscal fourth quarter in both Paper Packaging & Services (PPS) and Global Industrial Packaging (GIP).
  • The Company will report its fiscal fourth quarter 2023 financial results after the market closes on Wednesday, December 6, 2023.
  • Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statements.

Nelnet Reports Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 7, 2023
NNI, Risk, Security (finance), Payment, NYSE, Educational technology, Information, Loan servicing, Corporation, AGM, Cyprus Securities and Exchange Commission, GAAP, Disclosure, Consumer, Bank statement, Environment, EPC, Forecasting, Forest Law Enforcement and Governance Program, Investment, Failure, Climate change, Bank, Video game, Cryptocurrency, Beauty salon, System, Nelnet

The AGM operating segment reported net interest income of $51.5 million during the third quarter of 2023, compared with $62.9 million for the same period a year ago.

Key Points: 
  • The AGM operating segment reported net interest income of $51.5 million during the third quarter of 2023, compared with $62.9 million for the same period a year ago.
  • As of September 30, 2023, Nelnet Bank had a $468.8 million loan portfolio and total deposits, including intercompany deposits, of $947.4 million.
  • Nelnet Bank recognized net income after tax for the quarter ended September 30, 2023 of $1.7 million, compared with $0.8 million for the same period in 2022.
  • The dividend will be paid on December 15, 2023, to shareholders of record at the close of business on December 1, 2023.

NANOBIOTIX Announces Closing of Global Offering

Retrieved on: 
Tuesday, November 7, 2023
Cyprus Securities and Exchange Commission, Exercise, SVB Securities, American depositary receipt, Bloomberg, License, State Street, Guggenheim, Guggenheim Partners, Jefferies Group, Telephone, Form, Additional notification thresholds, Cancer, Patient, Security (finance), The 8th Floor, Floor, NANO, ADS, Madison Avenue, Private, Option, Attention, Prospectus, EU, Euronext

The U.S. Offering and the European Offering are referred to, together, as the “Global Offering”.

Key Points: 
  • The U.S. Offering and the European Offering are referred to, together, as the “Global Offering”.
  • Jefferies LLC, Leerink Partners and Guggenheim Securities acted as global coordinators and joint bookrunners for the Global Offering.
  • The ADSs (including the Additional ADSs) and Ordinary Shares offered in the Global Offering were offered pursuant to an effective shelf registration statement on Form F-3 (Registration No.
  • The Global Offering was made only by means of a prospectus and prospectus supplement that form a part of the registration statement.

NANOBIOTIX Announces Closing of Global Offering

Retrieved on: 
Tuesday, November 7, 2023
Common stock, Cyprus Securities and Exchange Commission, Exercise, SVB Securities, American depositary receipt, Bloomberg, License, State Street, Guggenheim, Guggenheim Partners, Jefferies Group, Telephone, Form, Additive manufacturing file format, Cancer, Patient, Security (finance), The 8th Floor, Floor, NANO, ADS, Madison Avenue, Note, AMF, Private, Option, Attention, Prospectus, EU, Euronext

PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the closing today (the “Closing”) of its global follow-on offering reserved to specified categories of investors, including after partial exercise by the underwriters of their option to purchase additional ordinary shares (the “Underwriters’ Option”) in the form of American Depositary Shares (“ADSs”).

Key Points: 
  • PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the closing today (the “Closing”) of its global follow-on offering reserved to specified categories of investors, including after partial exercise by the underwriters of their option to purchase additional ordinary shares (the “Underwriters’ Option”) in the form of American Depositary Shares (“ADSs”).
  • The U.S. Offering and the European Offering are referred to, together, as the “Global Offering”.
  • Jefferies LLC, Leerink Partners and Guggenheim Securities acted as global coordinators and joint bookrunners for the Global Offering.
  • The Global Offering was made only by means of a prospectus and prospectus supplement that form a part of the registration statement.

Melco Announces Unaudited Third Quarter 2023 Earnings

Retrieved on: 
Tuesday, November 7, 2023
Online, Relaxation, Studio, Tax, SM Investments, Public expenditure, Corporation, EBITDA, Cyprus Securities and Exchange Commission, Bank statement, Republic, City, Growth, EPS, COVID-19, Annual report, Depreciation, Capital expenditure, ADS, City of Dreams, AI, Mocha, Communications and Entertainment Limited, Morpheus, Video game, Bookkeeping, Tourism, Insurance, Adjustment, Dream, Altira Macau

Melco generated Adjusted Property EBITDA(1) of US$280.6 million in the third quarter of 2023, compared with negative Adjusted Property EBITDA of US$34.9 million in the third quarter of 2022.

Key Points: 
  • Melco generated Adjusted Property EBITDA(1) of US$280.6 million in the third quarter of 2023, compared with negative Adjusted Property EBITDA of US$34.9 million in the third quarter of 2022.
  • Rolling chip volume was US$4.43 billion for the third quarter of 2023 versus US$332.2 million in the third quarter of 2022.
  • The rolling chip win rate was 2.48% in the third quarter of 2023 versus 4.53% in the third quarter of 2022.
  • The mass market table games hold percentage was 32.1% in the third quarter of 2023, compared with 28.6% in the third quarter of 2022.

Novanta Announces Financial Results for the Third Quarter 2023

Retrieved on: 
Tuesday, November 7, 2023
Other Health, General Health, Machinery, Robotics, Technology, Medical Devices, Other Manufacturing, Health Technology, Engineering, Medical Supplies, Other Technology, Health, Manufacturing, Adjustment, Element, Sale, Adjusted gross income, Security (finance), Event, Tax, Public expenditure, Cyprus Securities and Exchange Commission, News, GAAP, Acquisition, Net income, Software, Social, Growth, Epidemic, EPS, Risk, Tax rate, Seizure, Pandemic, Forecasting, Benefit, Annual report, Table, Failure, Social Security Government Pension Offset, Bank, Video game, Film industry, Bookkeeping, Risk management, Novantae

In the third quarter of 2023, GAAP operating income was $30.3 million, compared to $28.7 million in the third quarter of 2022.

Key Points: 
  • In the third quarter of 2023, GAAP operating income was $30.3 million, compared to $28.7 million in the third quarter of 2022.
  • GAAP net income was $21.2 million in the third quarter of 2023, compared to $22.5 million in the third quarter of 2022.
  • GAAP diluted earnings per share (“EPS”) was $0.59 in the third quarter of 2023, compared to $0.63 in the third quarter of 2022.
  • Adjusted Diluted EPS was $0.85 in the third quarter of 2023, compared to $0.81 in the third quarter of 2022.